LadRx Corp (LADXD)

[Ecomike]

I was averaged in at $1.23 (and in way too debt already), and I added already to average down the day it dropped to nearly 40 cents. I am now at $1.02/share, and waiting on dry powder to add more. I still think this one is way, WAY undervalued. All we need is someone like NVS to announce a JV funding deal with CYTR for one of these block buster products they have and the stock will rocket. But no telling how long, or when that might happen. They have had profitable quarters off and on the last 3 years, and had JV partners before. And recently sold a shelved product to ANX. They still have lots of cash, a great blockbuster pipeline that has been blowing the lid off the news with test results that are almost unheard of (but few seem to be listening?), namely curing several terminal cancer patients that had been written off as incurable the last 12 months. And now we know what the price will be for the next funding round needed to cover future phase III trials, and the recent market panic sell off on the day the dilution news hit, did a pretty good job of showing us the next long term low I think. Only wild card left here I think is the world economy and the markets in general. If we get a nasty market wide, world wide sell off this month, then yes CYTR might go lower, but I watched well funded biotechs outperform others in 2008-09! In fact CYTR raised cash in 07-08 just before the prior crash, and bought RXII at the bottom, and made a pile of cash selling it off in 2010 to fund the last 18 months.